Detection of Chlamydia (CT) and Gonorrhea (NG)
NCT02055742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2017-12-07
Summary
To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the illumipro-10, with male urine, female urine, physician-collected (medical professional) endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic patient populations.
Conditions
- Chlamydia
- Gonorrhea
Interventions
- DEVICE
-
illumigene CT and NG assays, illumipro-10
Sponsors & Collaborators
-
Meridian Bioscience, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 14 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-01
- Primary Completion
- 2014-09-09
- Completion
- 2014-09-09
Countries
- United States
Study Locations
More Related Trials
-
A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples
NCT00827697 ·Status: COMPLETED
-
Clinical Study of a Diagnostic Device for NG, TV and CT in Women
NCT03852316 ·Status: COMPLETED ·Phase: NA
-
Cepheid Rectal Sample Validation Study
NCT02099760 ·Status: COMPLETED
-
Evaluation of the Atlas Genetics io® CTNG System
NCT03071510 ·Status: COMPLETED
-
Clinical Evaluation of the Click Sexual Health Test for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in Women
NCT04098900 ·Status: COMPLETED
-
Identigene STD Test Collection Kit Validation Study
NCT01471392 ·Status: UNKNOWN ·Phase: PHASE3
-
Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing
NCT01849653 ·Status: COMPLETED
-
Self-taken Penile Meatal Swabs for Chlamydia, Gonorrhoea and Mycoplasma Genitalium Detection
NCT04244994 ·Status: UNKNOWN ·Phase: NA
-
Home Screening for Chlamydia Surveillance
NCT00177437 ·Status: COMPLETED ·Phase: PHASE3
-
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
NCT00252096 ·Status: COMPLETED ·Phase: NA
-
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
NCT01638637 ·Status: COMPLETED
-
Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia
NCT01140022 ·Status: COMPLETED
-
Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study
NCT06216964 ·Status: RECRUITING ·Phase: NA
-
A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections
NCT06369220 ·Status: COMPLETED ·Phase: NA
-
Improving Maternal and Child Health Through Point-of-care STI Testing
NCT07290439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
NCT00115388 ·Status: COMPLETED ·Phase: NA
-
SYSTEMATIC: NAATS of Pooled Selftaken Versus Clinicantaken Swabs 1
NCT02371109 ·Status: COMPLETED
-
Self Sampling for Rapid Turnaround Testing in the Emergency Department
NCT03676816 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal Swabs
NCT03596151 ·Status: TERMINATED ·Phase: NA
-
The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.
NCT00207493 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Point of Care Rapid STI Test Optimization and Validation Extension
NCT06566677 ·Status: COMPLETED
-
Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System
NCT01733069 ·Status: COMPLETED
-
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NCT05286931 ·Status: RECRUITING ·Phase: NA
-
Emergency Department, Rapid Assessment for Sexually Transmitted Infection
NCT02386514 ·Status: COMPLETED
-
Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
NCT02019771 ·Status: COMPLETED